UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 100

Sortiert nach

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

British journal of cancer, 2013-05, Vol.108 (10), p.2045-2055

2013

Link zum Volltext

Verfügbarkeit prüfen

MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure

Investigational new drugs, 2009-08, Vol.27 (4), p.379-386

2009

Link zum Volltext

Verfügbarkeit prüfen

Cloning the Interleukin 1 Receptor from Human T Cells

Proceedings of the National Academy of Sciences - PNAS, 1989-11, Vol.86 (22), p.8946-8950

1989

Link zum Volltext

Verfügbarkeit prüfen

A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma

Cancer gene therapy, 2003-04, Vol.10 (4), p.251-259

2003

Link zum Volltext

Verfügbarkeit prüfen

Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice

Gene therapy, 2000-09, Vol.7 (17), p.1447-1457

2000

Link zum Volltext

Verfügbarkeit prüfen

Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen

The Journal of biological chemistry, 1986-12, Vol.261 (34), p.16210-16214

1986

Link zum Volltext

Verfügbarkeit prüfen

MUC1 as a target antigen for cancer immunotherapy

Expert review of vaccines, 2005-08, Vol.4 (4), p.493-502

2005

Link zum Volltext

Verfügbarkeit prüfen

Differential MUC 1 expression in normal and neoplastic human pancreatic tissue : An immunohistochemical study of 60 samples

American journal of clinical pathology, 1999-11, Vol.112 (5), p.635-640

1999

Link zum Volltext

Verfügbarkeit prüfen

Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas

Blood, 2004-09, Vol.104 (6), p.1631-1638

2004

Link zum Volltext

Verfügbarkeit prüfen

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

The journal of gene medicine, 2003-08, Vol.5 (8), p.690-699

2003

Link zum Volltext

Verfügbarkeit prüfen

Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment

Human gene therapy, 2000-07, Vol.11 (10), p.1417-1428

2000

Link zum Volltext

Verfügbarkeit prüfen

Evaluating the Impact of AB 705 on Remediation: A Teacher’s Perspective

Acres, Dustin B

2021

Link zum Volltext
ProQuest

Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L

Cancer gene therapy, 2005-02, Vol.12 (2), p.198-205

2005

Link zum Volltext

Verfügbarkeit prüfen

Lack of evidence for an immunosuppressive role for MUC1

Cancer Immunology, Immunotherapy, 1999-04, Vol.48 (1), p.22-28

1999

Link zum Volltext

Verfügbarkeit prüfen

The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer

Cancer Immunology, Immunotherapy, 2002-12, Vol.51 (11-12), p.645-654

2002

Link zum Volltext

Verfügbarkeit prüfen

Biomarkers associated with clinical outcome in advanced non-small cell lung cancer patients treated with TG4010

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.3027-3027

2009

Link zum Volltext

Verfügbarkeit prüfen

Phosphorylation of the CD8 antigen on cytotoxic human T cells in response to phorbol myristate acetate or antigen-presenting B cells

The Journal of immunology (1950), 1987-10, Vol.139 (7), p.2268

1987

Link zum Volltext

Verfügbarkeit prüfen

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

Journal of immunotherapy, 2000-09, Vol.23 (5), p.570-580

2000

Link zum Volltext

Verfügbarkeit prüfen

Randomized phase IIb trial evaluating the therapeutic vaccine TG4010 (MVA-MUC1-IL2) as an adjunct to chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8023-8023

2008

Link zum Volltext

Verfügbarkeit prüfen

A method for identifying soil catenas and determining map unit composition used in a reconnaissance soil survey in Tanzania

Geoderma, 1993-06, Vol.57 (4), p.387-404

1993

Link zum Volltext

Verfügbarkeit prüfen

Secretomers as a new tool for the monitoring of CTL responses

Cancer Immunology, Immunotherapy, 2005-06, Vol.54 (6), p.548-556

2005

Link zum Volltext

Verfügbarkeit prüfen

Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity

Cancer research (Chicago, Ill.), 2005-10, Vol.65 (20), p.9536-9546

2005

Link zum Volltext

Verfügbarkeit prüfen

Effects of platelet-derived growth factor and epidermal growth factor on antigen-induced proliferation of human T-cell lines

Immunology, 1985, Vol.54 (1), p.9-16

1985

Link zum Volltext

Verfügbarkeit prüfen

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

Cancer Immunology, Immunotherapy, 2000, Vol.48 (10), p.588-594

2000

Link zum Volltext

Verfügbarkeit prüfen

Metastatic Breast Tumour Regression Following Treatment by a Gene‐Modified Vaccinia Virus Expressing MUC1 and IL‐2

BioMed research international, 2003, Vol.2003 (3), p.194-201

2003

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 100

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(89)
Mit Volltextzugriff
(84)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(64)
Life Sciences & Biomedicine
(53)
Humans
(46)
Animals
(33)
Biological And Medical Sciences
(29)
Mice
(28)
Female
(25)
Immunology
(21)
Oncology
(21)
Immunotherapy
(19)
Medical Sciences
(17)
T-Lymphocytes - Immunology
(16)
Medicine, Research & Experimental
(15)
Research & Experimental Medicine
(15)
Lymphocyte Activation
(13)
Lymphocytes T
(13)
Biotechnology & Applied Microbiology
(12)
Fundamental And Applied Biological Sciences. Psychology
(12)
Male
(12)
Mice, Inbred Balb C
(11)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer

MVA-MUC1-IL2 vaccine immunotherapy (TG4010) improves PSA doubling time in patients with prostate cancer with biochemical failure

Cloning the Interleukin 1 Receptor from Human T Cells

A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma

Immune rejection of human dystrophin following intramuscular injections of naked DNA in mdx mice

Rapid phosphorylation and modulation of the T4 antigen on cloned helper T cells induced by phorbol myristate acetate or antigen

MUC1 as a target antigen for cancer immunotherapy

Differential MUC 1 expression in normal and neoplastic human pancreatic tissue : An immunohistochemical study of 60 samples

Adenovirus-mediated intralesional interferon-γ gene transfer induces tumor regressions in cutaneous lymphomas

Phase I immunotherapy with a modified vaccinia virus (MVA) expressing human MUC1 as antigen-specific immunotherapy in patients with MUC1-positive advanced cancer

Targeted macrophage cytotoxicity using a nonreplicative live vector expressing a tumor-specific single-chain variable region fragment

Evaluating the Impact of AB 705 on Remediation: A Teacher’s Perspective

Bypassing tumor-associated immune suppression with recombinant adenovirus constructs expressing membrane bound or secreted GITR-L

Lack of evidence for an immunosuppressive role for MUC1

The combination of a chemokine, cytokine and TCR-based T cell stimulus for effective gene therapy of cancer

Biomarkers associated with clinical outcome in advanced non-small cell lung cancer patients treated with TG4010

Phosphorylation of the CD8 antigen on cytotoxic human T cells in response to phorbol myristate acetate or antigen-presenting B cells

Recombinant vaccinia virus encoding human MUC1 and IL2 as immunotherapy in patients with breast cancer

Randomized phase IIb trial evaluating the therapeutic vaccine TG4010 (MVA-MUC1-IL2) as an adjunct to chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)

A method for identifying soil catenas and determining map unit composition used in a reconnaissance soil survey in Tanzania

Secretomers as a new tool for the monitoring of CTL responses

Fusokine interleukin-2/interleukin-18, a novel potent innate and adaptive immune stimulator with decreased toxicity

Effects of platelet-derived growth factor and epidermal growth factor on antigen-induced proliferation of human T-cell lines

MUC1-specific immune responses in human MUC1 transgenic mice immunized with various human MUC1 vaccines

Metastatic Breast Tumour Regression Following Treatment by a Gene‐Modified Vaccinia Virus Expressing MUC1 and IL‐2

Suchergebnisse filtern